Epigenetics and Nanomedicine
The Epigenetics and Nanomedicine research group was established in 2015 as a result of the CINN’s growing activity in the biomedical field.
The current research lines are focused on six main areas:
- Application of new technologies in the search for epigenetic biomarkers related to aging and human carcinogenesis that are useful in clinical practice.
- Development of nanoparticles for the administration of combination of antitumor epigenetic drugs.
- Identification of epigenetic changes in response to nanomaterials, particularly graphene and graphenic materials.
- In-situ analysis of subcellular architecture.
- New inorganic antimicrobial products.
- Omics in health: Advanced techniques to study the bioactive role of food
- Tissue engineering: Solutions against peri-implantitis, ceramic materials for long-lasting implants, bone substitutes.
- Identification and pharmacological manipulation of the molecular mechanisms involved in the signaling of Bone Morphogenetic Proteins (BMPs)
Our researchers lead 4 research groups of the Health Research Institute of the Principality of Asturias (ISPA):